Eli Lilly Analysis
SECTION 1
1.2 A) INTRODUCTION AND HISTORY TO DATE (Timeline) Information gathers from Eli Lilly web site
1880s
Lilly was one of the first companies to initiate a bona fide pharmaceutical research program, hiring a pharmaceutical chemist as its first scientist.
1920s
Our researchers collaborated with Frederick Banting and Charles Best of the University of Toronto to isolate and purify insulin for the treatment of diabetes, then a fatal disease with no effective treatment options. The work resulted in Lilly 's introduction of Iletin, the world 's first commercially available insulin product, in 1923.
1940
Lilly was among the first companies to develop a method to mass-produce penicillin, the world 's first antibiotic, marking the beginning of a sustained effort to fight infectious diseases.
1960s
Lilly launched the first of a long line of oral and injectable antibiotics in a new class called cephalosporins. Over the next two decades, the company pioneered important chemical breakthroughs that allowed the large-scale production of these products, which include Keflex® and Kefzol®.
1970s
Ceclor®, a member of the cephalosporin family, was launched and eventually became the world 's top-selling oral antibiotic. Lilly introduced Dobutrex®, an innovative and lifesaving cardiovascular product
1980s
The most significant breakthrough in diabetes care since the 1920s was marked by Lilly 's 1982 introduction of Humulin® insulin identical to that produced by the human body. Humulin is the world 's first human-health-care product created using recombinant DNA technology. Lilly later applied this technology to the introduction of Humatrope®, a new therapy for growth hormone deficiency in children
1990s
Lilly introduced a stream of innovative new products: Gemzar®, a drug for the treatment of pancreatic and non-small-cell lung cancer; ReoPro®, a cardiovascular drug that prevents blood clots following certain heart procedures, such as angioplasty; Zyprexa®, now the
1.2 A) INTRODUCTION AND HISTORY TO DATE (Timeline) Information gathers from Eli Lilly web site
1880s
Lilly was one of the first companies to initiate a bona fide pharmaceutical research program, hiring a pharmaceutical chemist as its first scientist.
1920s
Our researchers collaborated with Frederick Banting and Charles Best of the University of Toronto to isolate and purify insulin for the treatment of diabetes, then a fatal disease with no effective treatment options. The work resulted in Lilly 's introduction of Iletin, the world 's first commercially available insulin product, in 1923.
1940
Lilly was among the first companies to develop a method to mass-produce penicillin, the world 's first antibiotic, marking the beginning of a sustained effort to fight infectious diseases.
1960s
Lilly launched the first of a long line of oral and injectable antibiotics in a new class called cephalosporins. Over the next two decades, the company pioneered important chemical breakthroughs that allowed the large-scale production of these products, which include Keflex® and Kefzol®.
1970s
Ceclor®, a member of the cephalosporin family, was launched and eventually became the world 's top-selling oral antibiotic. Lilly introduced Dobutrex®, an innovative and lifesaving cardiovascular product
1980s
The most significant breakthrough in diabetes care since the 1920s was marked by Lilly 's 1982 introduction of Humulin® insulin identical to that produced by the human body. Humulin is the world 's first human-health-care product created using recombinant DNA technology. Lilly later applied this technology to the introduction of Humatrope®, a new therapy for growth hormone deficiency in children
1990s
Lilly introduced a stream of innovative new products: Gemzar®, a drug for the treatment of pancreatic and non-small-cell lung cancer; ReoPro®, a cardiovascular drug that prevents blood clots following certain heart procedures, such as angioplasty; Zyprexa®, now the
Citations: DATAMONITOR: Eli Lilly Incorporated, Inc. Ely Lilly, Inc. SWOT Analysis [serial online]. June 2010; 1-12. Available from: Business Source Complete, Ipswich, MA. Accessed November 20, 2011 Hovers: Eli Lilly Incorporated, Inc. Ely Lilly, Inc. SWOT Analysis [serial online]. June 2010; 1-12. Available from: Hovers Business Source Complete, Ipswich, MA. Accessed November 20, 2011